Research Site US026 — Seattle, Washington

Research Site US026 is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site US026 has participated in 1 clinical trials.

Therapeutic areas: Respiratory Syncytial Virus (RSV).

Sponsors: Novavax.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site US026?

Research Site US026 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site US026 conducted?

Research Site US026 has 1 clinical trials on record. Their work covers Respiratory Syncytial Virus (RSV).

Is Research Site US026 accredited by Crixeo Health?

Research Site US026 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site US026?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.